• Latest Posts

It’s World Diabetes Day! But What is Biotech Doing to Fight the Disease?

Update: After 25 years, MorphoSys Gets its First Antibody Approved

MorphoSys’ First Lanthipeptide Completes Phase I Successfully

Way to Success: What Role does Company Culture Play in Biotech?

Interview 20 Apr 2017

Which EU Immuno-Oncology Company are you Cheering for?

Interview 12 Apr 2017

Video Interview: How Morphosys Grew Into a Billion-Euro Biotech


What are the Best Countries to Recruit Biotech Talents in 2017?

Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?

Infographics 21 Feb 2017

Infographic: The Biggest Biotech Company in Each European Country

Infographics 13 Feb 2017

Infographic: What’s in Europe’s Immuno-oncology Pipeline?

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

The 10 Biggest Clinical Success Stories of 2016 in European Biotech